Christophe Weber
Chief Executive Officer bei TAKEDA PHARMACEUTICAL COMPANY LIMITED
Vermögen: 17 Mio $ am 31.03.2024
Profil
Christophe Weber ist ein Geschäftsmann, der an der Spitze von 5 verschiedenen Unternehmen gestanden hat und die Position des Präsidenten, CEO & Representative Director bei Takeda Pharmaceutical Co., Ltd. und des Präsidenten & Chief Executive Officer bei Takeda Italia SpA (einer Tochtergesellschaft von Takeda Pharmaceutical Co., Ltd.) innehat. Dr. Weber war zuvor Chairman & Chief Executive Officer bei Groupe GlaxoSmithKline SAS, President & Chief Executive Officer von Takeda Pharmaceuticals (Asia Pacific) Pte Ltd, Chief Executive Officer für GlaxoSmithKline Biologicals SA und President & General Manager-Vaccines Division bei GlaxoSmithKline Pharmaceuticals SA (Belgien). Er erhielt einen Bachelor-Abschluss von der Universit Jean Moulin Lyon 3, einen Doktortitel und einen Diplomabschluss von der Universität Lyon und einen Diplomabschluss von der Universite Lumiere Lyon 2.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2023 | 628 100 ( 0,04% ) | 17 Mio $ | 31.03.2024 |
Aktive Positionen von Christophe Weber
| Unternehmen | Position | Beginn |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Chief Executive Officer | 01.04.2015 |
Takeda Italia SpA
 Takeda Italia SpA Pharmaceuticals: MajorHealth Technology Takeda Italia SpA manufactures pharmaceutical products. The company was founded in 1781 and is headquartered in Rome, Italy. | President | - |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - |
Ehemalige bekannte Positionen von Christophe Weber
| Unternehmen | Position | Ende |
|---|---|---|
Takeda Pharmaceuticals (Asia Pacific) Pte Ltd.
 Takeda Pharmaceuticals (Asia Pacific) Pte Ltd. Drugstore ChainsRetail Trade Takeda Pharmaceuticals (Asia Pacific) Pte Ltd. sales pharmaceutical products. The company was founded on April 5, 2012 and is headquartered in Singapore. | Chief Executive Officer | - |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | - |
Groupe GlaxoSmithKline SAS
 Groupe GlaxoSmithKline SAS Financial ConglomeratesFinance Part of GSK Plc, Groupe GlaxoSmithKline SAS is an investment holding French company. The private company is based in Rueil-Malmaison, France. | Chief Executive Officer | - |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Chief Executive Officer | - |
Ausbildung von Christophe Weber
| University of Lyon | Doctorate Degree |
| Université Jean Moulin Lyon 3 | Undergraduate Degree |
| Universite Lumiere Lyon 2 | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private Unternehmen | 6 |
|---|---|
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Finance |
Takeda Italia SpA
Takeda Italia SpA Pharmaceuticals: MajorHealth Technology Takeda Italia SpA manufactures pharmaceutical products. The company was founded in 1781 and is headquartered in Rome, Italy. | Health Technology |
Takeda Pharmaceuticals (Asia Pacific) Pte Ltd.
Takeda Pharmaceuticals (Asia Pacific) Pte Ltd. Drugstore ChainsRetail Trade Takeda Pharmaceuticals (Asia Pacific) Pte Ltd. sales pharmaceutical products. The company was founded on April 5, 2012 and is headquartered in Singapore. | Retail Trade |
Groupe GlaxoSmithKline SAS
Groupe GlaxoSmithKline SAS Financial ConglomeratesFinance Part of GSK Plc, Groupe GlaxoSmithKline SAS is an investment holding French company. The private company is based in Rueil-Malmaison, France. | Finance |
